Betz Stephen F. bought CRNX
February 23, 2026 · Form 4 insider transaction
Betz Stephen F. bought 47,000 shares of Crinetics Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
47,000
Price
$0.00
Total value
N/A
InsiderBetz Stephen F.
Role—
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateFebruary 23, 2026
Filing dateFebruary 25, 2026
Shares owned after47,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The stock option shall vest and become exercisable in a series of forty-eight (48) successive equal monthly installments measured from the vesting commencement date of February 23, 2026.